Armata Pharmaceuticals, Inc. (ARMP) Depreciation USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2013 to 2024.
  • Armata Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $300 K, a 50% increase year-over-year.
  • Armata Pharmaceuticals, Inc. Depreciation for the twelve months ending March 31, 2024 was $1.1 M, a 25.9% increase year-over-year.
  • Armata Pharmaceuticals, Inc. annual Depreciation for 2023 was $1 M, a 11.1% increase from 2022.
  • Armata Pharmaceuticals, Inc. annual Depreciation for 2022 was $900 K, a 23% decline from 2021.
  • Armata Pharmaceuticals, Inc. annual Depreciation for 2021 was $1.17 M, a 4.94% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.1 M $300 K +$100 K +50% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1 M $400 K +$126 K +46% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $874 K $200 K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $874 K $200 K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $874 K $200 K -$26 K -11.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $900 K $274 K -$14 K -4.86% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $914 K $200 K -$100 K -33.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.01 M $200 K -$100 K -33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1.11 M $226 K -$55 K -19.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.17 M $288 K +$69 K +31.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $1.1 M $300 K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.1 M $300 K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.1 M $281 K -$14 K -4.75% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.11 M $219 K -$49 K -18.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $1.16 M $300 K -$100 K -25% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.26 M $300 K -$35 K -10.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.3 M $295 K -$53 K -15.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $1.35 M $268 K -$257 K -49% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 $1.61 M $400 K +$64 K +19% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.54 M $335 K -$66 K -16.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $1.61 M $348 K +$259 K +291% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $1.35 M $525 K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 $336 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $401 K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $89 K +$4 K +4.71% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q1 2017 $85 K +$12 K +16.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $73 K +$15 K +25.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q1 2015 $58 K +$40 K +222% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q1 2014 $18 K -$3 K -14.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q1 2013 $21 K Jan 1, 2013 Mar 31, 2013 10-Q/A 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.